title: Enteric glia inhibit intestinal epithelial cell proliferation partly through a TGF-beta1-dependent pathway.
abstract: Although recent studies have shown that enteric neurons control intestinal barrier function, the role of enteric glial cells (EGCs) in this control remains unknown. Therefore, our goal was to characterize the role of EGCs in the control of intestinal epithelial cell proliferation using an in vivo transgenic and an in vitro coculture model. Assessment of intestinal epithelial cell proliferation after ablation of EGCs in transgenic mice demonstrated a significant increase in crypt cell hyperplasia. Furthermore, mucosal glial network (assessed by immunohistochemical detection of S-100beta) is altered in colon adenocarcinoma compared with control tissue. In an in vitro coculture model of subconfluent Caco-2 cells seeded onto Transwell filters with EGCs, Caco-2 cell density and [3H]thymidine incorporation were significantly lower than in control (Caco-2 cultured alone). Flow cytometry analysis showed that EGCs had no effect on Caco-2 cell viability. EGCs induced a significant increase in Caco-2 cell surface area without any sign of cellular hypertrophy. These effects by EGCs were also seen in various transformed or nontransformed intestinal epithelial cell lines. Furthermore, TGF-beta1 mRNA was expressed, and TGF-beta1 was secreted by EGCs. Exogenously added TGF-beta1 reproduced partly the EGC-mediated effects on cell density and surface area. In addition, EGC effects on Caco-2 cell density were significantly reduced by a neutralizing TGF-beta antibody. In conclusion, EGCs have profound antiproliferative effects on intestinal epithelial cells. Functional alterations in EGCs may therefore modify intestinal barrier functions and be involved in pathologies such as cancer or inflammatory bowel diseases.
authors.affiliation: INSERM U 539, University of Nantes, Hôpital Hôtel Dieu, 44035 Nantes, France. michel.neunlist@univ-nantes.fr
authors.forename: M
authors.initials: M
authors.lastname: Neunlist
authors.forename: P
authors.initials: P
authors.lastname: Aubert
authors.forename: S
authors.initials: S
authors.lastname: Bonnaud
authors.forename: L
authors.initials: L
authors.lastname: Van Landeghem
authors.forename: E
authors.initials: E
authors.lastname: Coron
authors.forename: T
authors.initials: T
authors.lastname: Wedel
authors.forename: P
authors.initials: P
authors.lastname: Naveilhan
authors.forename: A
authors.initials: A
authors.lastname: Ruhl
authors.forename: B
authors.initials: B
authors.lastname: Lardeux
authors.forename: T
authors.initials: T
authors.lastname: Savidge
authors.forename: F
authors.initials: F
authors.lastname: Paris
authors.forename: J P
authors.initials: JP
authors.lastname: Galmiche
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D000818:Animals; D018938:Caco-2 Cells; D002455:Cell Division; D002460:Cell Line; D018920:Coculture Techniques; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000166:cytology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000166:cytology* / Q000294:innervation* / Q000473:pathology; D007414:Intestinal Neoplasms / Q000473:pathology*; D007421:Intestine, Small / Q000166:cytology* / Q000473:pathology; D051379:Mice; D009457:Neuroglia / Q000166:cytology* / Q000473:pathology; D012016:Reference Values; D053773:Transforming Growth Factor beta1 / Q000502:physiology*
chemical_list: D053773:Transforming Growth Factor beta1